Taveras Arthur 4
4 · X4 Pharmaceuticals, Inc · Filed Feb 14, 2022
Insider Transaction Report
Form 4
Taveras Arthur
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2022-02-11−928→ 7,107 total
Footnotes (3)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Shares withheld by X4 Pharmaceuticals Inc. to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units.
- [F3]Of the shares of common stock reported, 5,357 shares represent unvested restricted stock units.